Equity Details
Price & Market Data
Price: $1.00
Daily Change: -$0.04 / 4.00%
Daily Range: $0.95 - $1.06
Market Cap: $5,009,439
Daily Volume: 83,324
Performance Metrics
1 Week: -31.69%
1 Month: -35.33%
3 Months: -42.94%
6 Months: -90.29%
1 Year: -87.42%
YTD: -88.48%
About MetaVia Inc. (MTVA)
Understand the current valuation of MetaVia Inc. (MTVA). Trading at 1.00, the stock has observed a daily change of -$0.04 / 4.00%. A robust market capitalization of 5,009,439 underscores its market presence. Key performance indicators include YTD (-88.48%) and 1-year (-87.42%) returns.
Company Details
Employees: 8
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
MetaVia Inc., a clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, as well as completed Phase 1 clinical trial for the treatment of type 2 diabetes mellitus; and DA-1726, a novel oxyntomodulin analogue functioning as a GLP-1 receptor and glucagon receptor dual agonist, which is in Phase 1 trial for the treatment of obesity. The company's therapeutic programs include ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 for the treatment of cognitive impairment; and Gemcabene for the treatment of dyslipidemia. It has a license agreement with Pfizer Inc. for the research, development, manufacture, and commercialization of Gemcabene; and Dong-A ST, a sole manufacturer for the production of DA-1241 and DA-1726. The company was formerly known as NeuroBo Pharmaceuticals, Inc. and changed its name to MetaVia Inc. in November 2024. MetaVia Inc. is headquartered in Cambridge, Massachusetts. MetaVia Inc. operates as a subsidiary of Dong-A ST Co., Ltd.